Animal models of multiple system atrophy

Trends in Neurosciences

Volumn 28, Issue 9, 2005, Pages 501-506

  Stefanova, Nadia ^a   Tison, François ^b   Reindl, Markus ^a   Poewe, Werner ^a   Wenning, Gregor K ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; 3 NITROPROPIONIC ACID; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA SYNUCLEIN; OXIDOPAMINE; PROTEOLIPID PROTEIN; QUINOLINIC ACID;

AUTONOMIC DYSFUNCTION; BRAIN INJURY; CELL INCLUSION; CEREBELLUM DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION; GLIA; HISTOPATHOLOGY; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; NEUROPATHOLOGY; NONHUMAN; OLIVOPONTOCEREBELLAR ATROPHY; PARKINSON DISEASE; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SHY DRAGER SYNDROME; STRIATONIGRAL DEGENERATION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MICE; MULTIPLE SYSTEM ATROPHY; RATS;

EID: 23944510851     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2005.07.002     Document Type: Review

References (52)

1. G.K. Wenning Multiple system atrophy Lancet Neurol. 3 2004 93 103
2. G.K. Wenning What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J. Neurol. Neurosurg. Psychiatry 68 2000 434 440
3. J.H. Bower Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990 Neurology 49 1997 1284 1288
4. K.A. Jellinger Neuropathological spectrum of synucleinopathies Mov. Disord. 18 Suppl. 6 2003 S2 S12
5. S. Daniel The neuropathology and neurochemistry of multiple system atrophy C.J. Mathias R. Bannister Autonomic Failure 1999 Oxford University Press 321 328
6. J. Schwarz Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy J. Neurol. Neurosurg. Psychiatry 60 1996 98 101
7. K. Ishizawa Microglial activation parallels system degeneration in multiple system atrophy J. Neuropathol. Exp. Neurol. 63 2004 43 52
8. M.I. Papp Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) J. Neurol. Sci. 94 1989 79 100
9. M.G. Spillantini Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies Neurosci. Lett. 251 1998 205 208
10. K. Wakabayashi Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy Neurosci. Lett. 249 1998 180 182
11. S.M. Solano Expression of α-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease Ann. Neurol. 47 2000 201 210
12. A.B. Singleton α-Synuclein locus triplication causes Parkinson's disease Science 302 2003 841
13. P.J. Kahle Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes EMBO Rep. 3 2002 583 588
14. I. Yazawa Mouse model of multiple system atrophy α-synuclein expression in oligodendrocytes causes glial and neuronal degeneration Neuron 45 2005 847 859
15. 1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy Nat. Med. 6 2000 1388 1394
16. 1B-adrenergic receptor J. Biol. Chem. 276 2001 13738 13743
17. 1B-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation J. Neurochem. 83 2002 623 634
18. M.S. Kafka Alpha-adrenergic receptors in orthostatic hypotension syndromes Neurology 34 1984 1121 1125
19. B. Grijalba Adrenergic receptors in the cerebellum of olivopontocerebellar atrophy J. Neural Transm. Gen. Sect. 96 1994 135 142
20. U. Wüllner Probable multiple system atrophy in a German family J. Neurol. Neurosurg. Psychiatry 75 2004 924 925
21. G.K. Wenning Multiple system atrophy: sporadic or familial? Lancet 342 1993 681
22. M. Nishimura Contribution of the interleukin-1β gene polymorphism in multiple system atrophy Mov. Disord. 17 2002 808 811
23. M. Nishimura Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy Neurosci. Lett. 374 2005 218 221
24. O. Combarros Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy Mov. Disord. 18 2003 1385 1386
25. J. Infante Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-α gene polymorphisms and the risk for multiple system atrophy J. Neurol. Sci. 228 2005 11 13
26. D.W. Miller Expression of α synuclein mRNA in multiple system atrophy Func. Neurol. 19 2004 145 146
27. T. Ozawa Analysis of the expression level of α-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy Acta Neuropathol. (Berl.) 102 2001 188 190
28. L.E. Nee Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation Clin. Auton. Res. 1 1991 9 13
29. P.A. Hanna Multiple system atrophy: the putative causative role of environmental toxins Arch. Neurol. 56 1999 90 94
30. V. Chrysostome Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France Neuroepidemiology 23 2004 201 208
31. N. Vanacore Case-control study of multiple system atrophy Mov. Disord. 20 2005 158 163
32. D.J. Simpson Presence of 3-nitropropionic acid, in widely distributed pasture legumes in Britain Vet. Rec. 145 1999 169 171
33. N. Nakao, and P. Brundin Effects of α-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid Neuroscience 76 1997 749 761
34. P.O. Fernagut Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation Neuroscience 114 2002 1005 1017
35. N. Stefanova Oxidative stress in transgenic mice with oligodendroglial α-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy Am. J. Pathol. 166 2005 869 876
36. G.K. Wenning Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration Mov. Disord. 11 1996 522 532
37. C. Scherfler Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy) Neuroscience 99 2000 43 54
38. N. Stefanova Effects of pulsatile l-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy) Neurobiol. Dis. 15 2004 630 639
39. N. Stefanova Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration J. Neurosci. Res. 78 2004 87 91
40. L. Mantoan Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy) Acta Neuropathol. (Berl.) 109 2005 191 197
41. Scherfler, C. et al. Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy). J. Neural Transm. (in press)
42. Z. Puschban Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts Neuroscience 95 2000 377 388
43. Z. Puschban Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy) Exp. Neurol. 164 2000 166 175
44. M.F. Schocke In vivo magnetic resonance imaging of embryonic neural grafts in a rat model of striatonigral degeneration (multiple system atrophy) NeuroImage 12 2000 209 218
45. I. Ghorayeb Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration Exp. Neurol. 167 2001 133 147
46. R. Waldner No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy) Neuroscience 102 2001 581 592
47. I. Ghorayeb A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis Neuroscience 115 2002 533 546
48. N. Stefanova Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy) Acta Neuropathol. (Berl.) 106 2003 157 166
49. E. Diguet Effects of riluzole on combined MPTP+3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice J. Neural Transm. 112 2005 613 631
50. P.O. Fernagut MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration Exp. Neurol. 185 2004 47 62
51. I. Ghorayeb Toward a primate model of l-dopa-unresponsive parkinsonism mimicking striatonigral degeneration Mov. Disord. 15 2000 531 536
52. I. Ghorayeb Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3- nitropropionic acid model of striatonigral degeneration in monkeys Neurosci. Lett. 335 2002 34 38